Aro Biotherapeutics Employee Directory
Biotechnology ResearchPennsylvania, United States51-200 Employees
Aro Biotherapeutics is a biotechnology research company based in Philadelphia, Pennsylvania, focused on developing tissue-targeted genetic medicines. Its platform leverages Centyrins, a proprietary protein technology, to direct therapeutic payloads to specific tissues. The company maintains a wholly owned pipeline of Centyrin-based therapeutic candidates and collaborates with industry partners to expand tissue-specific targeting across a broad range of diseases. ABX1100 is a key program in its portfolio and has moved into clinical development, including a first-in-human study for Pompe Disease. As of 2026, the company notes ongoing advancement of ABX1100 as part of its broader pipeline of targeted genetic therapies.